| 2025-11-17 | Olsson Shawn | Chief Commercial Officer | Sale+OE | 10,000 | $26.10 | $261,022.18 | -39.6% | → |
| 2025-11-07 | MCCOLLUM JAMES W | Director | Buy | 10,500 | $22.79 | $239,278.20 | New | → |
| 2025-11-07 | Chevallard Daniel R. | Chief Financial Officer | Buy | 2,198 | $22.76 | $50,016.99 | +34.4% | → |
| 2025-09-30 | Versant Venture Capital VI, L.P. | - | Sell | 224,974 | $46.01 | $10,352,017.45 | -3.9% | → |
| 2025-09-18 | Versant Venture Capital VI, L.P. | - | Sell | 135,304 | $42.23 | $5,714,356.00 | -2.1% | → |
| 2025-08-26 | Versant Venture Capital VI, L.P. | - | Sell | 188,094 | $39.47 | $7,423,920.06 | -1.4% | → |
| 2025-08-18 | Versant Venture Capital VI, L.P. | - | Sell | 260,713 | $39.34 | $10,255,243.56 | -5.2% | → |
| 2025-07-10 | Versant Venture Capital VI, L.P. | - | Sell | 191,376 | $34.00 | $6,506,784.00 | -10.8% | → |
| 2025-06-27 | Versant Venture Capital VI, L.P. | - | Sell | 200,000 | $30.47 | $6,093,000.00 | -10.2% | → |
| 2025-06-20 | Versant Venture Capital VI, L.P. | - | Sell | 334,801 | $30.19 | $10,107,817.95 | -7.4% | → |
| 2025-06-10 | Versant Venture Capital VI, L.P. | - | Sell | 350,000 | $29.00 | $10,150,000.00 | -21.9% | → |
| 2024-05-14 | Chevallard Daniel R. | Chief Financial Officer | Buy | 3,188 | $15.68 | $49,987.84 | New | → |
| 2024-05-13 | MCCOLLUM JAMES W | Director | Buy | 31,332 | $15.99 | $501,092.68 | +6.3% | → |
| 2024-03-21 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | 998,009 | $15.03 | $15,000,075.27 | +33.1% | → |
| 2022-04-12 | Samsara BioCapital, L.P. | 10% Owner | Buy | 424,464 | $4.08 | $1,731,068.48 | +2.6% | → |
| 2022-04-11 | Gutry Phil | CHIEF BUSINESS OFFICER | Buy | 5,000 | $4.01 | $20,050.00 | +1.7% | → |
| 2022-01-24 | Samsara BioCapital, L.P. | 10% Owner | Buy | 123,000 | $8.94 | $1,099,100.00 | +0.8% | → |
| 2022-01-20 | Samsara BioCapital, L.P. | 10% Owner | Buy | 97,670 | $9.10 | $888,677.20 | +0.6% | → |